UK Stocks-Factors to watch on April 14

April 14 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Thursday, with futures FFIc1 up 0.3%.

* DUNELM GROUP: Dunelm DNLM.L said on Thursday its total sales jumped in the third quarter, as the British homeware retailer benefited from the reopening of stores after coronavirus curbs were eased.

* HAYS: British recruitment agency Hays Plc HAYS.L said on Thursday it would take a one-time hit of about 5 million pounds ($6.57 million) for costs related to exiting Russian operations, after posting a record quarter on strong hiring across its markets.

* REGULATOR: Britain's accounting watchdog will reclaim responsibility for authorising auditors of listed companies, which the government had delegated to professional accounting bodies, under proposals announced on Thursday.

* VALNEVA: Britain approved on Thursday Valneva's VLS.PA COVID-19 vaccine, making it the first country to give a nod to the French firm's coronavirus shot that is easier to store and involves a process widely used in making flu and polio vaccines.

* JUPITER EMERGING: The board of Jupiter Emerging & Frontier Income Trust intends to put forward formal proposals to shareholders to wind up the company, it said on Thursday.

* SHELL-PETROBRAS: Brazil's Petrobras PETR4.SA said it received 5.26 billion reais ($1.12 billion) from Shell SHEL.L regarding the compensation on the latter's 25% stake in the Atapu oil block.

* CARETECH-SHEIKH HOLDINGS: The co-founders of social care services firm CareTech CTH.L raised their takeover proposal for the British company to 850 million pounds ($1.11 billion) and matched a rival bid, while tabling another offer for investors seeking alternatives.

* SHELL: Brazil granted 59 exploratory blocks of oil and natural gas to 13 companies, including Shell SHEL.L , TotalEnergies TTEF.PA and 3R Petroleum RRRP3.SA .

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Amna Karimi and Muhammed Husain in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.